Details of the Standard Glass Lining IPO
A new issue of 1.50 crore shares for ₹210.00 crores and an offer to sell 1.43 crore shares worth ₹200.05 crores make up the Standard Glass Lining IPO, which is valued at ₹410.05 crores. On January 6, 2025, the IPO's bidding procedure began, and it ended on January 8, 2025. It is anticipated that the share distribution will be concluded on Thursday, January 9, 2025. On Monday, January 13, 2025, the IPO is tentatively planned to list on both the NSE and the BSE.How can I check the Standard Glass Lining IPO's Allotment Status online?
How to Verify the Standard Glass Lining Allotment Status on BSE
- Go to the BSE website's IPO allocation page.
- From the Issue Type dropdown menu, select 'Equity'.
- If the company name appears, choose 'Standard Glass Lining'.
- Put in your PAN or application number.
- 'Captcha' must be cleared for verification.
- To see the status of your allotment, choose the 'Search' option.
How to Verify the Standard Glass Lining Allotment Status on NSE
- The NSE website allows users to check their IPO Allotment Status.
- Log in (new users must register)
- From the "Enter Symbol" dropdown, choose "SGLTL."
- Put in your application number.
- Select "Get data."
How to Verify the Standard Glass Lining Allotment Status on Kfin Technologies
- Visit Kfin Technologies' official website.
- Choose among the five server links that are shown on the screen.
- Choose "Standard Glass Lining" from the selection of businesses.
- Choose either the Application Number, PAN, or Demat account number.
- Enter information according to your choice.
- To continue, clear the captcha.
- To view the status of the allocation, click Submit.
Overview of Standard Glass Lining's Business
Since its founding in September 2012, Standard Glass Lining Technology Limited has grown to become a leading supplier of engineering equipment to the chemical and pharmaceutical industries in India. Complete turnkey solutions, including design, engineering, manufacture, assembly, installation, and operational support, are provided by the company. Reaction systems, storage, separation, and drying systems, as well as plant engineering services, are all part of its broad product line. Serving a stellar clientele that includes prominent players in the sector such as Aurobindo Pharma, Cadila Pharmaceuticals, Laurus Labs, Granules India, and Piramal Pharma, the company specializes in equipment made from glass-lined materials, stainless steel, and nickel alloys.Subscription Status for Standard Glass Lining IPO Day 3 (January 8, 2025 End of Day)
By the end of the auction on January 8, 2025 (Day 3), the Standard Glass Lining IPO had been subscribed for 185.48 times, demonstrating the tremendous reaction to the offering. Retail investors subscribed 65.71 times, Qualified Institutional Buyers (QIBs) subscribed 327.76 times, and Non-Institutional Investors (NIIs) subscribed 275.21 times, demonstrating the impressive demand in the public issue across all categories. Bids over ₹10 lakh (bNII) were subscribed 302.21 times within the NII segment, whilst bids under ₹10 lakh (sNII) were subscribed 221.21 times.Making Use of IPO Proceeds
The company plans to support a number of key projects with the net revenues from the offering. A sizable amount will go into capital expenses for the purchase of new machinery and equipment. The money will also be used to pay back or prepay current debts, which will help the business and S2 Engineering Industry Private Limited, its fully owned subsidiary.Premium Grey Market (GMP)
According to Livemint, the Standard Glass Lining IPO's Grey Market Premium (GMP) is currently 91 ₹ per share. This indicates that shares of Standard Glass Lining Technology are trading on the gray market for ₹91 more than their issue price.Disclaimer: The Grey Market Premium (GMP) price is an unreliable market-related rumor with no clear foundation. The aforementioned quotation is based on news that was reported in the media and is just meant for informational reasons. Before making any investment decisions, the investor must conduct their own investigation. We do not trade, deal, or engage in the grey market, nor do we advocate or support such activity.
No comments:
Post a Comment